semaglutide europe Fake Ozempic and Wegovy drugs surge in – POLITICO US Market For Obesity Drugs
Description
Nuez A, Carro E, Torres-Aleman I
For now, its a waiting game, but one that could pay off in the future
GLP1-RAs have proven non-inferiority the CVD outcomes
Licensed pharmacies ensure regulatory oversight and quality control for GLP-1 weight loss treatments
Studies show that when GLP-1 therapy is discontinued, much of the weight tends to return unless behavioral, nutritional, and metabolic foundations are simultaneously addressed
$102bn market by 2030 In November 2023, investment banking company TD Cowen provided insight into the GLP-1 market
